Related Experiment Videos
Ultrastructural changes in lymphoma cells treated with hematoporphyrin and light
The American Journal of Pathology
|April 1, 1980
Summary
Hematoporphyrin photodynamic therapy causes lymphoma cell death. Ultrastructural studies reveal that mitochondria are the first cellular components affected, showing damage within minutes of treatment.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Hematoporphyrin exhibits photodynamic effects on lymphoma cells.
- Photodynamic therapy (PDT) is a promising cancer treatment modality.
Purpose of the Study:
- To investigate the initial cellular targets of hematoporphyrin-induced photodynamic therapy.
- To elucidate the ultrastructural changes in lymphoma cells following PDT.
Main Methods:
- In vitro studies using leukemic cells.
- Exposure of cells to hematoporphyrin followed by light activation.
- Transmission electron microscopy for ultrastructural analysis.
Main Results:
- Hematoporphyrin and light treatment led to extensive necrosis in vivo.
- In vitro, the first observed morphologic changes were within the mitochondria of leukemic cells.
- Mitochondrial damage included contraction, swelling, and eventual disruption within 5 minutes.
Conclusions:
- Mitochondria are the primary targets of hematoporphyrin photodynamic therapy.
- The observed mitochondrial damage may be due to a higher affinity for hematoporphyrin.
- These findings provide insight into the mechanism of PDT-induced cell death.